AbbVie in talks to buy biotech Revolution Medicines, WSJ reports
Jan 7 (Reuters) - AbbVie is in advanced talks to buy cancer-drug developer Revolution Medicines, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Shares of Revolution were up 10% in afternoon trading.
(Reporting by Puyaan Singh in Bengaluru; Editing by Alan Barona)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Next Big Crypto 2026: Dash and ChainOpera 100% Bullish as DeepSnitch AI Emerges as the 150x Gem with Massive Passive Income Potential
Bitcoin is the only “escape valve” left as the ECB warns a political tussle will soon destabilize the dollar
Asseto Finance Unveils BOND+ for OnChain Tokenized Fixed-Yield Investments
HYPE crypto price forms risky pattern as key Hyperliquid metrics dive
Trending news
MoreCrypto prices
More
